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Purpose: Acute anterior uveitis (AAU) is the most common form of uveitis; however, while it is presumed to have an
immunological basis, the precise underlying etiology remains elusive. Toll-like receptors (TLRs) have a key role in linking
innate and adaptive immunity, thereby forming a molecular bridge between microbial triggers and the development of
AAU. The purpose of this study was to investigate the role of TLR2 and TLR4 gene polymorphisms in the pathogenesis
of AAU.
Methods: The study comprised 225 confirmed cases of idiopathic or human leukocyte antigen (HLA) B27 (subtypes
B*2701-2759; HLA-B27)-related AAU and 2,534 population-based controls from the Blue Mountains Eye Study. All
participants were of Anglo-Celtic descent. Blood samples were collected for DNA extraction and genotyping. A total of
16 single nucleotide polymorphisms (SNPs) were selected for analysis and either directly genotyped or imputed to cover
the common variations within the TLR genes. Data were analyzed at the allelic, genotypic and haplotypic levels.
Results: Control subjects were significantly older than case subjects (p<0.0001). There was no significant difference in
the gender composition between the case and control cohorts (p=0.18). One TLR2 SNP (rs11938228) was found to be
associated with AAU at the allelic level (OR=1.28; p=0.017); however this association did not remain following adjustment
for age and sex (p=0.067). None of the SNPs at the TLR4 locus were found to differ significantly between cases or controls,
irrespective of adjustment for age and gender.
Conclusions: This study has confirmed that common TLR variants of moderate effect size do not predispose to AAU,
undermining the implication of reported mutations in the selective perturbations of TLR expression and function evident
in AAU.
Acute anterior uveitis (AAU) is the most common type
of uveitis. It is a leading cause of blindness and significant
cause  of  visual  impairment  in  western  populations  [1-4].
Although Human leukocyte antigen (HLA) B27 (subtypes
B*2701-2759; HLA-B27)-related AAU is the most common
identifiable form of AAU, approximately 50% of cases are
idiopathic with a presumed immune pathogenesis [5,6]. Other
genetic and environmental factors are involved in triggering
and promoting even HLA-B27-associated AAU.
There is a great deal of controversy surrounding the role
of infectious agents in non-infectious uveitis. Irrespective of
the  HLA-B27  status,  microbial  triggers,  especially  Gram-
negative  enterobacteria  such  as  Klebsiella,  Shigella,  and
Yersinia, have been implicated in the pathogenesis of AAU
[7,8] and related syndromes such as reactive arthritis. These
findings suggest that interactions between microbes and Toll-
like receptors (TLRs) may overcome the protective state of
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ocular immune privilege leading to intraocular inflammation.
The  uvea  is  highly  sensitive  to  lipopolysaccharide,  and
antigen-presenting cells (APCs) in the iris and ciliary body
have been shown to express functional TLR4, through which
microbial triggers could initiate AAU [9-11]. Furthermore,
TLR-expressing APCs form a crucial link between the innate
and adaptive arms of the immune response. APC stimulation
via  the  TLRs  results  in  production  of  proinflammatory
cytokines,  which  then  activate  and  prime  antigen-specific
naive T cells, eventually triggering adaptive immunity [10].
Recently,  TLRs  have  been  found  to  have  gene-specific
regulatory  mechanisms,  which  allow  for  variation  and
diversity in immune-pathway regulation [12]. Specifically,
TLR chromatin modifications are associated with transient
silencing of pro-inflammatory mediators, and priming of other
genes, which include antimicrobial effectors [12].
The role of infectious agents, particularly gram-negative
bacteria, in both human uveitis and experimental uveitis is
clear. It is plausible that TLRs expressed in the eye trigger
innate  and  then  adaptive  immunity  in  response  to  these
common infectious agents or pathogen-associated molecular
patterns.  This  immune  response  may  then  manifest  as
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2970intraocular inflammation characteristic of AAU. We proposed
that subtle differences in TLR protein expression (encoded for
by various polymorphisms in TLR genes) may lead to an
increased risk of AAU. In this study, we sought to definitively
determine whether common TLR variants predispose to AAU
in a Caucasian population.
METHODS
Subject  recruitment:  Ethical  approval  for  this  work  was
provided by the Human Research & Ethics Committee of the
Royal Victorian Eye and Ear Hospital (RVEEH, Melbourne,
Victoria, Australia). Approval for the Blue Mountains Eye
Study  (BMES)  was  obtained  from  the  relevant  Human
Research Ethics Committees of the University of Sydney and
Western Sydney Area Health Service (Sydney, Australia).
This study was conducted in accordance with the Declaration
of  Helsinki,  with  signed  informed  consent  obtained  from
participants at each visit of the study.
Patients with anterior uveitis were recruited from the
RVEEH and local private ophthalmology practices. As per the
inclusion criteria, participants were required to be Caucasian,
aged at least 18 years, able to provide informed consent, and
diagnosed by an ophthalmologist as has having either either
idiopathic or HLA-B27-related anterior uveitis. Participants
were excluded if an underlying cause for their AAU had been
diagnosed.  These  conditions  included  Behçets  syndrome,
Fuchs  heterochromic  cyclitis,  herpes  simplex,  reactive
arthritis,  sarcoidosis,  syphilis,  sympathetic  ophthalmia,
herpes zoster, and juvenile idiopathic arthritis.
Control subjects were derived from participants of the
BMES, a population-based cohort study of older Australians
aged 49 or older living in two postcode areas in western
Sydney.  This  is  an  ethnically  homogenous  population  of
Anglo-Celtic descendants. Control subjects of this study were
drawn from participants attending the second cross-sectional
survey of the BMES conducted between 1997 and 2001 [13].
Single  nucleotide  polymorphism  (SNP)  selection  and
genotyping: Data from The International HapMap Project
were used to select of a total of 16 SNPs that captures most of
the genetic diversity across the TLR2 and TLR4 loci. To match
the data used for imputation in BMES (see below), data were
sourced  from  the  National  Center  for  Biotechnology
Information Build 36 (HapMap Data Phase III/Rel#2, Feb09,
on NCBI36 B36 assembly, dbSNP b126). SNPs were selected
from the Centre d’Etude du Polymorphisme Humain from
Utah  population  of  the  HapMap  project,  using  pairwise
tagging,  with  an  r2  threshold  set  to  0.8  and  minor  allele
frequency (MAF) of 5%. The nine tagging SNPs covering the
TLR2 locus included: rs13150331 (G/A), rs7696323 (T/C),
rs1898830  (G/A),  rs1816702  (T/C),  rs4696483  (T/C),
rs11938228 (A/C), rs3804099 (C/T), rs3804100 (C/T), and
rs7656411 (G/T). Seven SNPs were required to tag TLR4:
rs1927914  (C/T),  rs1927911  (T/C),  rs11536878  (A/C),
rs5030717 (G/A), rs5030728 (A/G), rs1554973 (C/T), and
rs7846989 (C/T). To adjust for HLA-B27 status tagging SNPs
across  the  HLA-B  locus  were  also  selected  (rs2523612;
rs2596501;  rs9266095;  rs2523605;  rs2596472;  rs2395029;
rs2284178; and rs3094014).
Genomic DNA from case participants was extracted from
peripheral nucleated blood cells using a standard salting out
procedure  at  the  Western  Australian  DNA  Bank.  Case
genotyping was performed using the iPLEX Gold chemistry
(Sequenom Inc., San Diego, California) on an Autoflex mass
spectrometer at the Australian Genome Research Facility,
Brisbane, Australia.
Participants of the BMES (Cross-section II) who had
DNA available were genotyped (n=2,761) using the Illumina
Human 670-Quadv1 genotyping array at the Wellcome Trust
Centre  for  Human  Genetics,  Sanger  Institute,  Cambridge,
England (Appendix 1). Imputation was performed using the
1000 genomes data set (NCBI Build 36.1) as the imputation
backbone, using only SNPs passing quality control (minor
allele frequency [MAF] >0.01, genotyping call rate >0.95,
Hardy–Weinberg  p-value  >1×10−6).  Genotype  imputation
was performed for autosomal SNPs using MACH v1.0.16.
Imputed genotypes were excluded if their ratio of observed to
expected variance of imputed allele dosages (R2) <0.3 or a
MAF<0.01 or if they had a Hardy–Weinberg Equilibrium
p<1×10−6.  Four  SNPs  at  the  TLR2  locus  (rs13150331,
rs1816702,  rs3804099,  and  rs7656411),  two  SNPs  at  the
TLR4 (rs1927914 and rs1554973) locus, and all SNPs at the
HLA-B locus were directly genotyped in the BMES cohort.
Statistical analysis and power calculations: In Stata/SEM
10.0 (StataCorp, College Station, TX), a Student t-test and
χ2 test was used to compare differences in age and gender,
respectively, between cases and controls.
PLINK version 1.06 was used for analysis of genetic data
[14].  Allelic,  genotypic  (dominant,  recessive  and  co-
dominant) and haplotypic models were constructed for both
loci. Odds ratios (ORs) and 95% confidence intervals (CI)
were also calculated. Haplotypes were constructed based on
linkage disequilibrium block structure, as defined by Gabriel
and colleagues [15]. The logistic regression model for the
association between each SNP and the occurrence of AAU
incorporated  both  sex  and  age  as  covariates.  Additional
models also adjusted for haplotypes across the HLA-B locus.
A value less than 0.05 was considered statistically significant
following Bonferroni correction for multiple-test correction.
Power calculations were performed using PGA [16]. At the
p=0.05 significance level, this study had a power of 80% to
detect a disease-associated allele conferring a relative risk
≥1.5 for variants with a frequency >0.1. For variants that had
a minor allele frequency >0.05, this study had 80% power to
detect variants with a relative risk of 2 at the p=0.05 level.
RESULTS
Genotyping data were available for 2,759 participants (225
cases and 2,534 population-based controls). Participants were
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2971aged between 18 and 92 years (mean=62 years; SD=9.82,
95%CI=61.72–62.46). Controls were significantly older than
cases (p<0.0001). There was no significant difference in the
gender composition between the case and control cohorts
(p=0.18); approximately 57% of the subjects were female.
Demographics of the study cohort are presented in Table 1.
All variants at the TLR2 locus were within the quality
control  (QC)  parameters.  The  allele  frequencies  of  nine
TLR2 SNPs in AAU cases and healthy controls are displayed
in Table 2, in conjunction with the allelic association results.
One SNP (rs11938228) was found to be nominally associated
with  AAU  (p=0.017,  before  Bonferroni  adjustment).  The
crude OR for developing AAU and having the A allele at this
SNP was 1.28 (95% CI: 1.04–1.56). However, this variant was
found  not  to  be  significant  following  age-  and  gender-
adjustment (p=0.067). The SNP rs11938228 that was found
to  be  statistically  significant  at  the  allelic  level  remained
significant under the co-dominant genotypic level only before
adjustment for age and sex (p=0.032). This SNP reached a
nominal level of statistical significance under the dominant
genetic model following adjustment for age and sex (p=0.045,
Table 3). However, the significance of this association was
not retained following Bonferroni correction. None of the nine
SNPs  were  implicated  under  a  recessive  model  before  or
following age- and gender-adjustment (Table 3).
At the TLR2 locus, two haplotype blocks were identified
under the “solid spine” block definition, as displayed in Figure
1.  Block  1  was  defined  by  SNP  pair,  rs13150331  and
rs7696323  and  block  2  comprises  all  SNPs  between
rs1898830  and  rs3804100.  There  was  no  significant
difference in the frequency of any of the common haplotypes
between the case subjects and control participants in block 1
TABLE 1. DEMOGRAPHIC FEATURES OF STUDY COHORT.
Characteristic Cases Controls p value
Number 225 2534  
Number female (%) 118 (52%) 1446 (57%) 0.18
Mean age (SD; 95%CI) 50 (15.7; 47.9 - 52.1) 63 (8.3; 62.8–63–5) <0.0001
TABLE 2. ALLELIC ASSOCIATION AT THE TLR2 LOCUS ON CHROMOSOME 4Q31.
          Unadjusted    Adjusted*  
SNP Minor
allele
fcase fcontrol p value OR (95% CI) χ2 p value OR (95% CI) t-stat
rs13150331 G 0.44 0.41 0.216 1.13 (0.93–1.38) 1.53 0.650 1.05 (0.85–1.31) 0.45
rs7696323 T 0.32 0.32 0.690 0.96 (0.78–1.18) 0.16 0.927 0.99 (0.79–1.25) −0.09
rs1898830 G 0.38 0.35 0.208 1.14 (0.93–1.39) 1.59 0.293 1.13 (0.90–1.40) 1.05
rs1816702 T 0.11 0.11 0.673 1.07 (0.79–1.45) 0.18 0.652 0.92 (0.65–1.31) −0.45
rs4696483 T 0.13 0.11 0.099 1.27 (0.96–1.70) 2.72 0.513 1.12 (0.80–1.56) 0.65
rs11938228 A 0.40 0.34 0.017 1.28 (1.04–1.56) 5.72 0.067 1.23 (0.99–1.53) 1.83
rs3804099 C 0.41 0.43 0.420 0.92 (0.76–1.12) 0.65 0.659 0.95 (0.77–1.18) −0.44
rs3804100 C 0.05 0.07 0.133 0.71 (0.46–1.11) 2.26 0.342 0.80 (0.50–1.27) −0.95
rs7656411 G 0.24 0.26 0.243 0.87 (0.69–1.10) 1.37 0.654 0.94 (0.74–1.21) −0.45
           Abbreviations: f, frequency; OR, odds ratios; 95%CI, 95% confidence interval; t-stat, t-statistic. *Adjusted for age and sex.
TABLE 3. GENOTYPIC ASSOCIATION AT THE TLR2 LOCUS ON CHROMOSOME 4Q31 ADJUSTED FOR AGE AND SEX.
  Co-dominant Dominant Recessive
SNP p value OR (95% CI) p value OR (95% CI) p value OR (95% CI)
rs13150331 0.669 1.05 (0.84–1.31) 0.671 1.07 (0.78–1.49) 0.761 1.06 (0.72–1.58)
rs7696323 0.525 0.92 (0.70–1.20) 0.647 1.08 (0.79–1.47) 0.362 0.78 (0.47–1.32)
rs1898830 0.605 1.07 (0.84–1.36) 0.129 1.28 (0.93–1.75) 0.942 0.98 (0.63–1.55)
rs1816702 0.229 0.48 (0.14–1.59) 0.854 0.97 (0.66–1.40) 0.228 0.23 (0.02–2.53)
rs4696483 0.753 1.12 (0.55–2.26) 0.526 1.12 (0.78–1.61) 0.78 1.22 (0.30–4.96)
rs11938228 0.151 1.19 (0.94–1.51) 0.045 1.39 (1.01–1.91) 0.419 1.20 (0.77–1.85)
rs3804099 0.443 0.91 (0.72–1.15) 0.622 1.09 (0.78–1.51) 0.169 0.75 (0.50–1.13)
rs3804100 0.613 0.76 (0.27–2.17) 0.362 0.79 (0.48–1.31) 0.629 0.60 (0.07–4.83)
rs7656411 0.889 0.98 (0.71–1.34) 0.585 0.92 (0.67–1.25) 0.978 0.99 (0.53–1.84)
           Abbreviations: OR, odds ratios; 95%CI, 95% confidence interval.
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haplotype in block 2 (ACCCTT) was found to occur more
frequently in control subjects compared to cases (21.0% vs
17.3% respectively, p=0.031); however, this did not survive
Bonferonni correction.
All  TLR4  variants  were  found  to  pass  QC.  The
frequencies of seven TLR4 SNPs in AAU cases and healthy
controls are displayed in Table 4, along with the results from
allelic association. None of the SNPs were found to differ
significantly between cases or controls, irrespective of the
adjustment for age and gender. Additionally, no significant
association was identified under a co-dominant or recessive
genotypic  model  (Table  5).  Under  the  dominant  model,
rs1927911 was the only SNP that approached significance,
revealing a nominal association with AAU following age and
sex-adjusted (Table 5).
On investigating the haplotype associations at the TLR4
locus, two blocks were identified under the “solid spine” block
definition, as displayed in Figure 1. Block 1 was defined by
all SNPs between rs1927914 and rs5030717 and block 2 as
SNPs  rs5030728  to  rs7846989.  None  of  the  imputed
haplotypes were found to differ significantly between the case
and control cohorts.
Three  SNPs  across  the  HLA-B  locus  (rs2523612;
rs9266095; and rs2523605) were found to be out of Hardy–
Weinberg Equilibrium and were subsequently excluded from
analysis. There was no significant change in TLR3 or TLR4
allelic or genotypic results following adjustment for HLA-B
haplotypes (data not shown).
DISCUSSION
The proteins encoded by TLR2 and TLR4 are phylogenetically
conserved pattern recognition receptors of immune cells like
Figure 1. Linkage disequilibrium at toll-like receptor (TLR) loci. A: TLR2; B: TLR4.
TABLE 4. ALLELIC ASSOCIATION AT THE TLR4 LOCUS ON CHROMOSOME 9Q33.
          Unadjusted     Adjusted*  
SNP Minor
Allele
fcase fcontrol p value OR (95% CI) χ2 p value OR (95% CI) t-stat
rs1927914 C 0.31 0.33 0.250 0.88 (0.72–1.09) 1.32 0.281 0.88 (0.69–1.11) −1.08
rs1927911 T 0.22 0.26 0.093 0.82 (0.65–1.03) 2.82 0.068 0.78 (0.60–1.02) −1.83
rs11536878 A 0.10 0.12 0.156 0.79 (0.57–1.09) 2.01 0.314 0.84 (0.59–1.19) −1.01
rs5030717 G 0.10 0.09 0.719 1.06 (0.77–1.47) 0.13 0.709 0.93 (0.64–1.35) −0.37
rs5030728 A 0.31 0.30 0.462 1.08 (0.88–1.33) 0.54 0.494 1.09 (0.86–1.37) 0.68
rs1554973 C 0.24 0.26 0.216 0.87 (0.69–1.09) 1.53 0.585 0.93 (0.72–1.20) −0.55
rs7846989 C 0.10 0.10 0.830 1.04 (0.75–1.43) 0.05 0.387 1.17 (0.82–1.67) 0.87
           Abbreviations: f, frequency; OR, odds ratios; 95%CI, 95% confidence interval; t-stat, t-statistic. *Adjusted for age and sex.
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2973macrophages and neutrophils that have a fundamental role in
activation of innate immunity [17,18]. They are one of the first
lines  of  host  defense  and  recognize  pathogen-associated
molecular patterns associated with various infectious agents
[17].  This  in  turn  initiates  the  proinflammatory  cytokine
cascade  necessary  for  development  of  effective  immunity
through  the  transcription  factor,  nuclear  factor-kappa  B
pathway [18]. TLR2 binds various lipoproteins, including
gram-positive bacterial components such as peptidoglycan
[10]. TLR4 has been implicated in signal transduction events
induced by lipopolysaccharide found in the majority of gram-
negative bacteria, which is pivotal in the pathogenesis of some
cases of non-infectious immune-mediated AAU [8,10].
Despite an observed difference in TLR expression and
function [9,19] in patients with active AAU, our study found
no statistically significant association between common SNPs
at the TLR2 or TLR4 loci and AAU. Given the vital role
TLRs have in both the innate and adaptive immune systems
[20], our results suggest that changes in TLR expression and
function, not polymorphisms, may be associated with disease
development. Given that the TLRs are involved in various
inflammatory diseases such as inflammatory bowel disease,
rheumatoid arthritis and psoriasis, all of which are recognized
systemic associations of HLA-B27 AAU [21,22], our findings
may also indicate that the underlying pathogenic mechanism
in isolated AAU differs from HLA-B27 AAU.
Chang  and  colleagues  [19,23]  reported  a  significant
reduction in the levels of TLR2 expression in patients with
active AAU as a result of TLR activation by gram-negative
and/or  gram-positive  bacterial  products,  for  example
lipopolysaccharides  or  peptidoglycans,  respectively.
Conversely,  selective  functional  hyporesponsiveness  to
TLR4  stimulation  was  demonstrated,  wherein,  cytokine
production was markedly reduced [19]. Given that the patients
had active AAU at the time of testing, the lipopolysaccharide
hyporesponsiveness was consistent with a functional state of
endotoxin  tolerance  induced  by  recent  exposure  to
lipopolysaccharide [19,24]. In a preliminary investigation in
the  genetic  contribution  of  TLR2  and  TLR4,  Chang  and
colleagues genotyped the Arg753Gln (rs5743708) TLR2 and
Asp299Gly  TLR4  variants  in  nine  patients  with  AAU.
Although no statistically significant difference was identified,
this  previous  work  was  underpowered  and  would  fail  to
identify other exonic or cis-acting variants, which may alter
gene  expression.  Interestingly,  despite  identifying  an
increased expression of TLR3 and TLR4 in buccal mucosa of
patients with Behçet's disease, Durrani and colleagues failed
to identify any significantly associated SNP in these genes
[25].
Intraperitoneal  administration  of  endotoxin  or
lipopolysaccharide gives rise to an endotoxin-induced uveitis
(EIU) in rodent and is one of the best animal models of human
AAU  [26,27].  Interestingly,  there  is  variation  in  rodent
susceptibility to EIU, which may reflect the importance of
genetic and environmental factors in disease predisposition in
humans. In EIU, the lipopolysaccharide hyporesponsiveness
observed in certain mice can be attributed to a point mutation
located in the coding region of the TLR4 gene, consequently
disrupting downstream signal transduction [10,28]. However,
our  results  do  not  support  this  EIU  evidence  which  has
indicated a transient state of hyporesponsiveness to TLR4
stimulation induced by a pre-exposure to lipopolysaccharide
in lieu of functional TLR4 gene mutations.
Strengths of our study include that it was based on a
biologically  strong  and  plausible  hypothesis,  with  a  large
sample  size  of  2,759  participants  (225  cases  and  2,534
controls) and reasonable power to detect a common variant of
modest  effect  size.  Although  imputation  is  a  boon  in  the
context of producing a powerful study design, it can be a bane
in the absence of strong linkage disequilibrium. Fortunately,
despite using imputed data in control participants, we had
excellent call rates (>95%) and imputation parameters at both
loci. Our use of historic control data did not allow us to directly
determine HLA-B27 carrier status, rather only SNP genotypes
and haplotypes across the HLA-B gene could be analyzed.
In summary, we undertook a large case-control study to
investigate  the  influence  of  TLR  polymorphisms  on
predisposition to AAU. We found no strong evidence for
common TLR2 or TLR4 variants and idiopathic AAU in the
Caucasian  population.  Clearly,  further  work  investigating
TABLE 5. GENOTYPIC ASSOCIATION AT THE TLR4 LOCUS ON CHROMOSOME 9Q33 ADJUSTED FOR AGE AND SEX.
  Co-Dominant Dominant Recessive
SNP p value OR (95% CI) p value OR (95% CI) p value OR (95% CI)
rs1927914 0.596 0.93 (0.72–1.21) 0.177 0.81 (0.60–1.10) 0.901 0.97 (0.59–1.60)
rs1927911 0.312 0.84 (0.59–1.18) 0.056 0.74 (0.54–1.01) 0.489 0.79 (0.40–1.55)
rs11536878 0.894 1.04 (0.55–1.97) 0.247 0.8 (0.54–1.17) 0.832 1.15 (0.32–4.07)
rs5030717 0.526 1.24 (0.64–2.40) 0.557 0.88 (0.59–1.33) 0.499 1.58 (0.42–5.90)
rs5030728 0.26 1.16 (0.90–1.50) 0.862 1.03 (0.76–1.40) 0.214 1.34 (0.83–2.25)
rs1554973 0.973 1.01 (0.74–1.38) 0.433 0.88 (0.65–1.20) 0.823 1.07 (0.58–1.98)
rs7846989 0.811 0.88 (0.32–2.46) 0.329 1.21 (0.83–1.76) 0.782 0.75 (0.10–5.83)
            Abbreviations: OR, odds ratios; 95%CI, 95% confidence interval.
Molecular Vision 2011; 17:2970-2977 <http://www.molvis.org/molvis/v17/a320> © 2011 Molecular Vision
2974possible trans-acting TLR variants that alter gene expression
and function should be performed. The quest for etiological
factors other than HLA-B27 is fundamental for monitoring
disease onset and progression. Eventually we hope to target
specific  steps  in  the  pathogenic  pathway,  potentially
revolutionising therapeutic regimens for this sight-threatening
ocular condition.
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